Bridgefront Capital, LLC Catalent, Inc. Transaction History

Bridgefront Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $220,702 - $360,680	4,857 New	4,857 $319,000
Q2 2022 Aug 12, 2022	BUY	$87.2 - $114.05 $191,927 - $251,024	2,201 New	2,201 $236,000
Q4 2021 Feb 10, 2022	SELL	$119.57 - $139.07 $237,585 - $276,332	-1,987 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$109.17 - $142.35 $216,920 - $282,849	1,987 New	1,987 $264,000
Q1 2021 May 17, 2021	SELL	$101.51 - $125.27 $643,979 - $794,712	-6,344 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$85.88 - $105.36 $544,822 - $668,403	6,344 New	6,344 $660,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgefront Capital, LLC with notifications on news.